Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healthpeak Properties Inc V.DOC


Primary Symbol: DOC

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in and manage real estate focused on healthcare discovery and delivery. It has a diversified portfolio of high-quality healthcare properties across three core asset classes of lab, outpatient medical, and continuing care retirement community (CCRC) real estate. The Company’s segments include Lab, Outpatient medical and CCRC. The lab segment properties contain laboratory and office space, are leased primarily to biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Outpatient Medical segment includes outpatient medical buildings and hospitals. Outpatient medical buildings typically contain physicians’ offices and examination rooms.


NYSE:DOC - Post by User

Post by AwareInvestoron Feb 21, 2021 4:48pm
377 Views
Post# 32622618

CloudMD: Canaccord Raises Price Target To $3.75

CloudMD: Canaccord Raises Price Target To $3.75
Wednesday morning, it was announced that CloudMD Software & Services is acquiring VisionPros, a vertically integrated eyecare platform. The deal will cost CloudMD C$60 million along with a potential one-time C$40 million earnout. The C$60 million comes in one C$30 million cash payment and one C$30 million payment in common shares of the company. Following this, they also announced a C$45 million bought deal, which was upsized yesterday morning to C$55 million.
 
CloudMD currently has five analysts covering the company with a weighted 12-month price target of C$3.91. This is slightly up from the average in January, which was C$3.33. One analyst has a strong buy rating, while the other four analysts have buy ratings.

https://thedeepdive.ca/cloudmd-canaccord-raises-price-target-to-3-75/
<< Previous
Bullboard Posts
Next >>